These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8297381)

  • 61. [Changes in the contractile and sarcoplasmatic protein in a traumatically injured myocardium].
    Alekseeva LM
    Dokl Akad Nauk SSSR; 1965 Sep; 164(3):716-9. PubMed ID: 5873650
    [No Abstract]   [Full Text] [Related]  

  • 62. Basic identity of certain drug responses of the canine and human myocardium.
    WALTON RP
    Arch Int Pharmacodyn Ther; 1962 Dec; 140():615-22. PubMed ID: 13998747
    [No Abstract]   [Full Text] [Related]  

  • 63. FKBP12 binds to the cardiac ryanodine receptor with negative cooperativity: implications for heart muscle physiology in health and disease.
    Richardson SJ; Thekkedam CG; Casarotto MG; Beard NA; Dulhunty AF
    Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220169. PubMed ID: 37122219
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Ryanodine Receptor as a Sensor for Intracellular Environments in Muscles.
    Kobayashi T; Kurebayashi N; Murayama T
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639137
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TRIC-A regulates intracellular Ca
    Zhou X; Li A; Lin PH; Zhou J; Ma J
    Pflugers Arch; 2021 Mar; 473(3):547-556. PubMed ID: 33474637
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Blood concentration of tacrolimus and age predict tacrolimus-induced left ventricular dysfunction after bone marrow transplantation in adults.
    Kanazawa K; Iwai-Takano M; Kimura S; Ohira T
    J Med Ultrason (2001); 2020 Jan; 47(1):97-105. PubMed ID: 31792638
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Redox Dependent Modifications of Ryanodine Receptor: Basic Mechanisms and Implications in Heart Diseases.
    Nikolaienko R; Bovo E; Zima AV
    Front Physiol; 2018; 9():1775. PubMed ID: 30574097
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiac T-Tubule Microanatomy and Function.
    Hong T; Shaw RM
    Physiol Rev; 2017 Jan; 97(1):227-252. PubMed ID: 27881552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Isoproterenol Promotes Rapid Ryanodine Receptor Movement to Bridging Integrator 1 (BIN1)-Organized Dyads.
    Fu Y; Shaw SA; Naami R; Vuong CL; Basheer WA; Guo X; Hong T
    Circulation; 2016 Jan; 133(4):388-97. PubMed ID: 26733606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The couplonopathies: A comparative approach to a class of diseases of skeletal and cardiac muscle.
    Ríos E; Figueroa L; Manno C; Kraeva N; Riazi S
    J Gen Physiol; 2015 Jun; 145(6):459-74. PubMed ID: 26009541
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FK506-Binding Proteins and Their Diverse Functions.
    Tong M; Jiang Y
    Curr Mol Pharmacol; 2015; 9(1):48-65. PubMed ID: 25986568
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Species- and chamber-specific responses of 12 kDa FK506-binding protein to temperature in fish heart.
    Korajoki H; Vornanen M
    Fish Physiol Biochem; 2014 Apr; 40(2):539-49. PubMed ID: 24048915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins.
    Girgenrath T; Mahalingam M; Svensson B; Nitu FR; Cornea RL; Fessenden JD
    J Biol Chem; 2013 May; 288(22):16073-84. PubMed ID: 23585572
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases.
    Marx SO; Marks AR
    J Mol Cell Cardiol; 2013 May; 58():225-31. PubMed ID: 23507255
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calcium cycling proteins and heart failure: mechanisms and therapeutics.
    Marks AR
    J Clin Invest; 2013 Jan; 123(1):46-52. PubMed ID: 23281409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The ryanodine receptor in cardiac physiology and disease.
    Kushnir A; Marks AR
    Adv Pharmacol; 2010; 59():1-30. PubMed ID: 20933197
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ion channels, transporters, and pumps as targets for heart failure therapy.
    Doshi D; Marx SO
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):273-8. PubMed ID: 19365280
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6.
    George CH; Sorathia R; Bertrand BM; Lai FA
    Biochem J; 2003 Mar; 370(Pt 2):579-89. PubMed ID: 12443530
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological modulation of intracellular Ca(2+) channels at the single-channel level.
    Koulen P; Thrower EC
    Mol Neurobiol; 2001; 24(1-3):65-86. PubMed ID: 11831555
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.
    Bultynck G; De Smet P; Rossi D; Callewaert G; Missiaen L; Sorrentino V; De Smedt H; Parys JB
    Biochem J; 2001 Mar; 354(Pt 2):413-22. PubMed ID: 11171121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.